Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Antivascular Endothelial Growth Factor Injection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Antivascular Endothelial Growth Factor Injection

Published:2024-10 Issue: Volume:273 Page:113913
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Lee Chien-Chung^ORCID,Chiang Ming-Chou,Chu Shih-Ming,Wu Wei-Chi,Ho Margaret Ming-Chih,Lien Reyin

Publisher

Elsevier BV

Reference48 articles.

1. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010;Blencowe;Pediatr Res,2013

2. Prevalence of severe visual disability among preterm children with retinopathy of prematurity and association with adherence to best practice guidelines;Norman;JAMA Netw Open,2019

3. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study;Good;Pediatrics,2005

4. Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study;Kang;Invest Ophthalmol Vis Sci,2018

5. Incidence and early course of retinopathy of prematurity. The cryotherapy for Retinopathy of Prematurity Cooperative Group;Palmer;Ophthalmology,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experiencia con el uso de bevacizumab intravítreo en el manejo de la retinopatía del prematuro tipo I en un país latinoamericano;Archivos de la Sociedad Española de Oftalmología;2024-09

2. Experience with the use of intravitreal bevacizumab in cases with type I retinopathy of prematurity in a Latin American country;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-09

3. Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity;BMC Ophthalmology;2024-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3